Chinese Biotechs Raise $212m Through Major VC/PE Deals in November

 
• By Dexter Jie Yan

Leading the group were Trinomab Biotech, which develops antibodies for infectious diseases, and cell and gene developers BRL Medicine and XellSmart.

funding
Chinese investors' sentiment seemed to warm up in November • Source: Shutterstock

More from China

More from Focus On Asia